These benefits, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assistance the strategy of focusing on ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked